🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
0.8532
+0.0166 (1.98%)
At close: Nov 18, 2026, 4:00 PM EST
0.8532
0.00 (0.00%)
After-hours: Nov 18, 2026, 4:00 PM EST

Marker Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
142533492379
Market Cap Growth
-7.63%-25.40%-31.89%115.29%-71.23%13.36%
Enterprise Value
5724311242
Last Close Price
0.841.493.115.502.669.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
6.137.015.0514.776.4663.58
PB Ratio
1.331.481.793.481.161.80
P/TBV Ratio
1.351.481.793.481.161.80

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.222.053.699.493.5234.02

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-----0.27
Net Debt / Equity Ratio
-0.86-0.96-1.03-1.07-0.60-0.69
Net Debt / EBITDA Ratio
---1.280.690.82
Net Debt / FCF Ratio
0.951.341.760.920.441.00
Asset Turnover
0.140.170.340.130.070.02
Quick Ratio
5.757.676.225.251.823.28
Current Ratio
6.268.396.365.572.143.56
Return on Equity (ROE)
-59.21%-68.81%-65.81%-83.47%-62.20%-117.42%
Return on Assets (ROA)
-38.69%-37.83%-35.50%-35.36%-24.12%-43.38%
Return on Capital Employed (ROCE)
-100.90%-74.00%-59.90%-103.80%-74.30%-71.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-51.84%-48.96%-32.23%-16.85%-131.80%-53.05%
FCF Yield
-67.14%-48.36%-32.76%-33.63%-118.78%-38.52%
Buyback Yield / Dilution
-51.63%-70.49%-1.94%-5.49%-9.16%-62.64%
SEC Filings: 10-K · 10-Q